Showing results (271-280 of 965) with videos related to
Sort By:
Pageof 97
Critical Care Clinics|March 17, 2020
Microvascular Dysfunction in the Critically IllCan Ince, Daniel De Backer, Philip R MayeuxComprehensive Psychiatry|July 1, 1988
Psychosis, behavioral disturbance, and the use of neuroleptics in dementiaD P Devanand, H A Sackeim, R MayeuxJAMA|March 12, 1997
Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigationA J Slooter, M X Tang, C M van Duijn, et al.Neurology|September 26, 2001
A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonusS J Frucht, E D Louis, C Chuang, et al.Life Sciences|July 11, 1983
Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not that of alpha methyl-p-tyrosineA Reches, M N Hassan, V R Jackson, et al.The Laryngoscope|February 1, 1988
Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia)A Blitzer, M F Brin, S Fahn, et al.Brain Research|November 18, 1985
Presynaptic inhibition of dopamine synthesis in rat striatum: effects of chronic dopamine depletion and receptor blockadeA Reches, H R Wagner, V Jackson-Lewis, et al.Neurology|February 1, 1997
Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's diseaseE D Louis, L A Klatka, Y Liu, et al.Archives of Neurology|July 1, 1996
Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patientsS L Pullman, P Greene, S Fahn, et al.Brain Research|January 2, 1989
Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidenceJ L Cadet, M Katz, V Jackson-Lewis, et al.Pageof 97